Work

Phase 1/1b study of PRGN-3005 autologous UltraCAR-T cells manufactured overnight for infusion next day to advanced stage platinum resistant ovarian cancer patients.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.5590

Authors: John B. Liao, Sasha E. Stanton, Marion Chakiath, Roshanak Semnani, Rutul R. Shah, Tasha Tan, Helen Sabzevari, Amy Lankford, Mary L. Disis

Institutions: University of Washington Medical Center, Providence Portland Medical Center, University of Washington

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379281273

Cites:

Cited by: 11

Related to: 10